ArticleJournal of translational medicine2017

Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.

Yoonjin Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.